Generative AI is already helping health care organizations improve operational efficiency and patient experiences, but it also has the potential to transform care delivery. Explore leaders’ key questions about GenAI’s value and how to improve efficiency while delivering compassionate patient experiences.
GenAI and the future of health care
Generative AI (GenAI) has the potential to reshape the health care experience for both patients and providers. This opportunity is bigger than individual use cases; it lies in creating an interoperable ecosystem that weaves together data, decisions and actions across the care journey.
When implemented in this way, GenAI could improve care continuity. Consider today’s typical health care experience, marked by multiple logins, disparate records and gaps in communication. An AI-enabled care pathway could streamline the process from start to finish with:
Health care organizations are not yet realizing GenAI’s full potential, but many are already seeing value through targeted applications. We spoke with Deloitte Digital’s health care leaders to get their perspective on where organizations have used GenAI to create meaningful value, what can slow progress and what it takes to scale responsibly. Here’s what they had to say:
1. What are some high-value areas where GenAI can drive efficiency and enhance patient care across the health care sector?
Value today comes from efficiency improvements and reduced friction across both patient and provider experiences. Rather than replace clinical judgment, leading GenAI use cases automate routine tasks, streamline clinical interactions and make it easier for patients to get the information and guidance they need. Common applications fall into three broader categories: provider support, patient support and operational efficiency.
While these use cases create value across the care journey, the potential of GenAI in health care depends on moving from fragmented applications to a cohesive, interoperable ecosystem that connects data, workflows and decisions across the care journey. This can multiply the impact of AI, enabling personalized care, smarter resource allocation and more thorough care decision support.
Provider support:
Patient support:
Operational efficiency:
2. What are some common roadblocks to effective GenAI implementation in health care?
Patient care inherently requires trust and accuracy, so some common obstacles to AI adoption in health care stem from concerns around liability and reputational damage. Organizations want to feel confident that the tools will protect patients while delivering measurable value. Obstacles can include:
3. What’s important for health care organizations to consider when scaling GenAI?
Health care organizations that effectively implement and scale GenAI now can create value for their business and patients. Balancing the adoption of new technology with the intricacies of patient care requires a cautious and disciplined approach, which should include:
4. What are some recent examples of effective implementations of GenAI in health care?
We’re seeing exciting pilots and implementations across the health care industry that combine back-office efficiency with patient journey improvements. For example:
Expanding opportunities to improve care delivery
As patients grow to expect frictionless, automated interactions, and clinicians aim to streamline workflows, GenAI has the potential to transform the care journey. Organizations that move beyond individual applications of AI to a more connected approach are likely to be better positioned to realize measurable value while keeping people at the center of the interaction.
Patients expect providers to help them understand their diagnosis and what to do next. That kind of guidance isn’t always built into clinical training. GenAI is beginning to help close that gap—supporting the patient journey while still keeping human judgment at the center.
– Courtney R. Sherman | Principal, Customer Engineering, Deloitte Consulting LLP
About the authors
Courtney R. Sherman is a principal at Deloitte Consulting LLP, leading the Innovation and Digital Product practice. She focuses her time on health care and life sciences across providers, payers and manufacturers. With over 20 years of experience, Courtney leads work that puts the “end user” in the center through the Human Centered Design approach, ensuring future products, services and experiences provide value to both the user and the business.
Holly Darov is the practice leader for the Marketing Strategy and Transformation team within Deloitte Digital. With more than 20 years of experience working with CMOs, business unit leaders and brand teams, Holly has expertise in operating model design, strategic transformation, and commercial capabilities design.
Deepak Gulati is a principal in Deloitte's Health Care practice who designs, develops and delivers AI-driven digital solutions to drive member and patient engagement objectives. He has more than 25 years of consulting experience at Deloitte and serves both health care payers and provider clients.
Sources
1. Jim Rowan, Nitin Mittal, Parth Patwari and Ed Burns, “The agentic reality check: Preparing for a silicon-based workforce,” Deloitte Insights, December 10, 2025.